Nureca Limited has informed the Exchange about "Investor Presentation"
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nureca Limited shared its Q4 and FY25 investor presentation alongside its audited results. The company posted strong Q4 FY25 revenue of INR 480 million, up 161% year-on-year, while full-year FY25 revenue grew 26% to INR 1,730 million. The business swung to profitability, with FY25 profit after tax of INR 49 million compared to just INR 3.1 million last year, and Q4 PAT of INR 25.7 million versus a loss of INR 41 million a year ago. The company highlighted that it is debt-free with 92% of revenue coming from online channels, and it added a new distribution tie-up with Swiggy alongside existing quick-commerce partners Blinkit and Zepto. A new manufacturing facility in Punjab was approved and the US FDA registration for its Mohali plant was renewed for continued exports. Promoter group member Aryan Goyal purchased 355,721 shares (3.55%) during the quarter.
The sharp return to profitability and strong revenue growth signal a clear business turnaround, which should be viewed positively by shareholders. The new manufacturing capacity, quick-commerce expansion, and insider buying add confidence in the growth story, though margins remain thin and online-dependence carries competitive risk.